Viewing Study NCT02232035


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-02-20 @ 6:37 PM
Study NCT ID: NCT02232035
Status: UNKNOWN
Last Update Posted: 2014-09-04
First Post: 2014-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Diazepam at the Active Phase of Labor
Sponsor: Navy General Hospital, Beijing
Organization:

Study Overview

Official Title: Intravenous Injection of Diazepam at the Beginning of Active Phase of Labor
Status: UNKNOWN
Status Verified Date: 2014-09
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Prolonged labour can lead to increased maternal and neonatal mortality and morbidity due to increased risks of maternal exhaustion, postpartum haemorrhage and sepsis, fetal distress and asphyxia and requires early detection and appropriate clinical response. The risks for complications of prolonged labour are much greater in poor resource settings. Active management of labour versus physiological, expectant management, has shown to decrease the occurrence of prolonged labour. Administering sedatives during labour could also lead to faster and more effective dilatation of the cervix. Interventions to shorten labour, such as sedatives, can be used as a preventative or a treatment strategy in order to decrease the incidence of prolonged labour. As the evidence to support this is still largely anecdotal around the world. (Cochrane Database of Systematic Reviews 2013,CD009243.pub3.; Cochrane Database of Systematic Reviews 2012, CD009223.pub2.)

Hypothesis: Diazepam reduced the duration of labor and the severity of pain in labor.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: